[Cancer Management and Research] In this review, the authors explore barriers to greater use of radiotherapy related to wrong perceptions and lack of knowledge in both physicians and patients that may be contributing to a lack of referrals to radiation oncology.
[OncoTargets and Therapy] This review of proton therapy discusses its physical basis, rationale for its use in patients with lymphoma, and the potential disadvantages and uncertainties that may limit its use; and offers a critical review of the dosimetric studies comparing the risk of latent radiation injuries between proton and photon radiotherapy.
Progression-free survival no different at five years when radiotherapy is used only if the cancer returns.
Adjuvant docetaxel given to men who underwent radiotherapy for intermediate- or high-risk prostate cancer and who were on androgen deprivation therapy did not lower their risk of PSA progression, a study found.
Adjuvant radiotherapy after surgery may prolong biochemical recurrence-free survival.
[Journal of Hepatocellular Carcinoma]
An overview of safe handling concerns regarding handling and administration of a recently approved receptor-binding radionuclide.
Updates include adjuvant radiotherapy for patients with adverse pathologic findings, hormonal therapies.
Antihormone treatment also recommended in conjunction with radiotherapy.
Survival benefit seen for radiotherapy after ABVD regimen, but difference not statistically significant.
